Racial (black-white) divergence in the association between adiponectin and arterial stiffness in asymptomatic young adults: The Bogalusa heart study

American Journal of Hypertension

Volumn 21, Issue 5, 2008, Pages 553-557

  Nguyen, Quoc M ^a   Srinivasan, Sathanur R ^a   Xu, Ji Hua ^a   Chen, Wei ^a   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AORTA FLOW; ARTERIAL STIFFNESS; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY FLOW; HEART RATE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEGRO; PRIORITY JOURNAL; PULSE WAVE; RACE DIFFERENCE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AFRICAN AMERICANS; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; ELASTICITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; LOUISIANA; MALE; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PULSATILE FLOW; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 42549127788     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.14     Document Type: Article

References (35)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270:26746-26749.
2. Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257:167-175.
3. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 2000; 102:1296-1301.
4. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277:37487-37491.
5. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-1935.
6. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291:1730-1737.
7. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III. cellular and molecular clues to heart and arterial aging. Circulation 2003; 107:490-497.
8. Safar ME, Henry O, Meaume S. Aortic pulse wave velocity: an independent marker of cardiovascular risk. Am J Ger Cardiol 2002; 11:295-298.
9. McEniery CM, Wilkinson IB, Avolio AP. Age, hypertension and arterial function. Clin Exp Pharmacol Physiol 2007; 34:665-671.
10. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-943.
11. Urbina EM, Srinivasan SR, Kieltyka RL, Tang R, Bond MG, Chen W, Berenson GS. Correlates of carotid artery stiffness in young adults: The Bogalusa Heart Study. Atherosclerosis 2004; 176:157-164.
12. Bhuiyan AR, Srinivasan SR, Chen W, Paul TK, Berenson GS. Correlates of vascular structure and function measures in asymptomatic young adults: The Bogalusa Heart Study. Atherosclerosis 2006; 189:1-7.
13. Mahmud A, Feely J. Adiponectin and arterial stiffness. Am J Hypertens 2005; 18:1543-1548.
14. Araki T, Emoto M, Yokoyama H, Maeno T, Hatsuda S, Mori K, Koyama H, Shoji T, Inaba M, Nishizawa Y. The association of plasma adiponectin level with carotid arterial stiffness. Metablolism 2006; 55:587-592.
15. Störk S, Bots ML, Angerer P, von Schacky C, Grobbee DE, Angermann CE, Seufert J. Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis 2007; 194:e147-e153.
16. Din-Dzietham R, Couper D, Evans G, Arnett DK, Jones DW. Arterial stiffness is greater in African Americans than in whites: evidence from the Forsyth County, North Carolina, ARIC cohort. Am J Hypertens 2004; 17:304-313.
17. Chaturvedi N, Bulpitt CJ, Leggetter S, Schiff R, Nihoyannopoulos P, Strain WD, Shore AC, Rajkumar C. Ethnic differences in vascular stiffness and relations to hypertensive target organ damage. J Hypertens 2004; 22:1731-1737.
18. Patel DA, Srinivasan SR, Xu J-H, Chen W, Berenson GS. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2006; 55:1551-1557.
19. Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR Jr. Serum adiponectin in young adults - interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 2004; 14:492-498.
20. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 2004; 53:2473-2478.
21. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In Lewis LA, Opplt JJ (eds), CRC Handbook of Electrophoresis (Lipoproteins), Vol. 3. CRC: Boca Raton, Florida, 1983, pp. 185-203.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
23. Al-Shaer MH, Choueiri NE, Correia ML, Sinkey CA, Barenz TA, Haynes WG. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans. Int J Cardiol 2006; 109:201-206.
24. Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrières J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001; 19:381-387.
25. Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, Sakkinen PA, Lyles MF, Spurgeon HA, Lakatta EG, Kuller LH. Correlates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study. Am J Hypertens 2002; 15:16-23.
26. Li H, Srinivasan SR, Chen W, Xu JH, Li S, Berenson GS. Vascular abnormalities in asymptomatic, healthy young adult smokers without other major cardiovascular risk factors: the Bogalusa Heart Study. Am J Hypertens 2005; 18:319-324.
27. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti A. Endothelium, aging, and hypertension. Curr Hypertens Rep 2006; 8:84-89.
28. Puranik R, Celermajer DS. Smoking and endothelial function. Prog Cardiovasc Dis 2003; 45:443-458.
29. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation 2004; 109:2511-2517.
30. Houghton JL, Philbin EF, Strogatz DS, Torosoff MT, Fein SA, Kuhner PA, Smith VE, Carr AA. The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine. J Am Coll Cardiol 2002; 39:1314-1322.
31. Campia U, Choucair WK, Bryant MB, Waclawiw MA, Cardillo C, Panza JA. Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans. J Am Coll Cardiol 2002; 40:754-760.
32. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 1989; 149:780-788.
33. Patel DA, Srinivasan SR, Xu JH, Li S, Chen W, Berenson GS. Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metabolism 2006; 55:699-705.
34. Tsioufis C, Dimitriadis K, Selima M, Thomopoulos C, Mihas C, Skiadas I, Tousoulis D, Stefanadis C, Kallikazaros I. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J 2007; 28:1162-1169.
35. Ferreira AV, Viana MC, Mill JG, Asmar RG, Cunha RS. Racial differences in aortic stiffness in normotensive and hypertensive adults. J Hypertens 1999; 17:631-637.